![]() |
Volumn 50, Issue 4, 2014, Pages 615-617
|
Remission with fingolimod in a case of demyelinating polyneuropathy
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FINGOLIMOD;
IMMUNOGLOBULIN G;
INTERLEUKIN 1BETA;
INTERLEUKIN BETA 1B;
OLIGOCLONAL BAND;
STEROID;
UNCLASSIFIED DRUG;
IMMUNOSUPPRESSIVE AGENT;
PROPANEDIOL DERIVATIVE;
SPHINGOSINE;
ADULT;
ATAXIA;
ATROPHY;
BRAIN DAMAGE;
CASE REPORT;
CONTRAST ENHANCEMENT;
DEMYELINATING DISEASE;
DEMYELINATING POLYNEUROPATHY;
DIPLOPIA;
DISEASE ACTIVITY;
DISEASE SEVERITY;
HUMAN;
LETTER;
MALE;
MULTIPLE SCLEROSIS;
MUSCLE ACTION POTENTIAL;
MUSCLE STRENGTH;
NERVE CONDUCTION;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NYSTAGMUS;
OPTIC NEURITIS;
PARESTHESIA;
PERONEUS NERVE PARALYSIS;
POLYNEUROPATHY;
PRIORITY JOURNAL;
PROPRIOCEPTION;
PROTEIN CEREBROSPINAL FLUID LEVEL;
QUADRIPLEGIA;
REMISSION;
SENSORY NERVE CONDUCTION;
TENDON REFLEX;
WALKING DIFFICULTY;
YOUNG ADULT;
ADOLESCENT;
ANALOGS AND DERIVATIVES;
COMPLICATION;
DEMYELINATING DISEASES;
DRUG EFFECTS;
ELECTROSTIMULATION;
PHYSIOLOGY;
POLYNEUROPATHIES;
PROCEDURES;
ADOLESCENT;
DEMYELINATING DISEASES;
ELECTRIC STIMULATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
NEURAL CONDUCTION;
POLYNEUROPATHIES;
PROPYLENE GLYCOLS;
SPHINGOSINE;
|
EID: 84922479851
PISSN: 0148639X
EISSN: 10974598
Source Type: Journal
DOI: 10.1002/mus.24311 Document Type: Letter |
Times cited : (6)
|
References (4)
|